<DOC>
	<DOCNO>NCT01351155</DOCNO>
	<brief_summary>In patient acute respiratory failure ( ARF ) undergo noninvasive ventilation ( NIV ) , main complication use mask development decubitus , sometimes severe painful force suspension NIV . The lesion mainly locate nasal bridge , level skin thin place directly bone particularly vulnerable injury consequence friction pressure induce movement mask . The strategy prevention treatment commonly adopt application hydrocolloid . However , precise data lack demonstration effectiveness device possibility use protective device . The purpose study evaluate usefulness large-scale three different system protection vs. protection prevent development decubitus lesion patient receive NIV episode ARF .</brief_summary>
	<brief_title>Prevention Damage Induced Facial Mask Ventilation</brief_title>
	<detailed_description>NIV form ventilatory support popular overall world . The patient interface commonly use course NIV far nasal oronasal mask . The main complication use mask development decubitus , sometimes severe painful force suspension NIV . The decubitus mainly locate nasal bridge , level skin thin place directly bone . According Meduri et al . ( Chest 1996 ) duration NIV , age , type respiratory failure , pressure use ventilation level albumin influence development necrosis . Severe skin injury ulceration necrosis occur approximately 10 % patient receive NIV train service . In multicenter evaluation new face mask dedicate NIV ( Gregoretti et al , Intens Care Med 2002 ) describes development NIV-induced decubitus 100 % control group treat mask `` traditional '' , average grade 2.79 scale Assessment Standard range 1 ( erythema ) 4 ( necrosis ) . The strategy prevention treatment commonly adopt application appropriately shaped hydrocolloid . However , data relate use protective system prevention NIV-induced decubitus limit controversial . In first pilot study ( Callaghan et al , Professional Nurse 1998 , author compare protective efficacy two type `` dress '' ( Granuflex , Spenco Dermal 10 patient , 10 patient ) vs non-randomized control group ( 10 patient ) : 30 patient total . In work , present problem inter-observer variability , `` Granuflex group '' ( Duoderm ) show great protective effect ( 3 vs. 7 lesion `` Spenco Dermal group '' vs 9 lesion control group ) . Recently , large study , Weng ( Intensive Crit Care Nurs 2008 ) compare efficacy two device ( Tegaderm tegasorb ) vs. control group 90 patient ( 30 per group ) undergo NIV . The rate lesion significantly low treat group ( 53 % Tegaderm ; Tegasorb 40 % ) control group ( 96.7 % ) , significant difference two interventional arm incidence timing onset injury . Therefore , give limited data currently available regard effectiveness choice protective device consideration continuous expansion NIV acute setting , opinion 's seem u justified perform control study compare different type device term skin protection NIV .</detailed_description>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<criteria>Hypoxemichypercapnic acute respiratory failure ( O2therapy ) : 1. pH &lt; 7.30 , 2 . PaCO2 &gt; 50 mmHg , 3 . PaO2/FiO2 &lt; 250 , 4. respiratory rate &gt; 25/min use accessory respiratory muscle Pure Hypoxemic acute respiratory failure ( O2therapy ) : 1. pH &gt; 7.35 2 . PaCO2 &lt; 50 mmHg 3 . PaO2/FiO2 &lt; 250 4. respiratory rate &gt; 25/min use accessory respiratory muscle For type acute respiratory failure : Signed informed consent patient next keen . Age 20 year 's old 1. cardiac arrest 2. severe hemodynamic instability ( &gt; 1 vasoactive amine 24 hour ) 3. acute coronary syndrome ( instable angina/AMI ) 4. refusal NIV 5. anatomic abnormality interfere mask fit 6. preexistent nasal lesion ; 7 . NIV &lt; 24 hour 8. kwon hypersensitivity hydrocolloid polyurethane 9. cancel inform consent</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>acute respiratory failure</keyword>
	<keyword>noninvasive ventilation</keyword>
</DOC>